Vectors and method for genetic immunization
AssigneeNature Technology Corporation
InventorJames A. Williams
Life of this patent
Estimating the term…
Abstract
Improved DNA vaccine plasmids are disclosed that contain novel immunostimulatory RNA compositions. The improved plasmids eliminate all extraneous sequences, incorporate a novel antibiotic free short RNA based selectable marker, increase eukaryotic expression using a novel chimeric promoter, improve yield and stability during bacterial production, and improve immunostimulation. These vectors are utilized in immunization to elicit improved immune responses or therapy to induce type 1 interferon production.
Claims18
-15. (canceled)
A method for modifying the response of an individual or eukaryotic cell to at least one vector comprising the steps of:
- a. obtaining at least one vector containing at least one RNA element comprising a VARNA, and at least one additional immunostimulatory RNA element, and
- b. optionally cloning at least one gene encoding a protein or peptide into said vector(s), and
- c. delivering said vector(s) to said individual or said eukaryotic cell, and
- d. evaluating immune response or type 1 interferon production after said delivery of said vector(s),
- whereby said combination of VARNA and at least one additional immunostimulatory RNA element improves immune response and/or improves type 1 interferon production by said individual or said eukaryotic cell without reducing antigen expression.
A method for modifying the response of a individual or eukaryotic cell to a vector comprising the steps of:
- a. obtaining a vector comprising at least one immunostimulatory RNA element that comprises a tRNA, optionally a linker, an RNA to be expressed, and an RNA polymerase III promoter arranged in opposite orientation to said tRNA, such that transcription of said RNA is convergent, and
- b. optionally cloning at least one gene that encode a protein or peptide into said vector, and
- c. delivering said vector to a eukaryotic cell, and
- d. evaluating immune response or type 1 interferon production after said delivery of said vector,
- whereby said RNA element improves immune response and/or improves type 1 interferon production by said individual or said eukaryotic cell.
A composition of matter comprising two immunostimulatory RNA elements, further comprising:
- a. a VARNA RNA element or a VARNA derivative RNA element, and
- b. a second RNA element,
- whereby the combination of said VARNA RNA element with said second RNA element improves type 1 interferon production and/or immune response without reducing antigen expression.
A method for modifying the response of an individual to a vector comprising the steps of:
- a. cloning at least one gene that encodes a protein or peptide into a vector that contains a mitochondrial R region, and
- b. optionally cloning at least one immunostimulatory RNA element into said vector, and
- c. delivering said vector to a eukaryotic cell, and
- d. evaluating immune response after said delivery of said vector,
- whereby said mitochondrial R region improves immune response to said protein or said peptide.
A method for selection and propagation of antibiotic marker-free covalently closed, super-coiled DNA replicon, such as a plasmid, a cosmid, or a bacterial artificial chromosome, in E. coli, comprising the steps of:
- a. cloning a RNA-OUT antisense RNA into said DNA replicon, and
- b. transforming said RNA-OUT antisense RNA containing DNA replicon into bacterial cells that express a selectable chromosomal gene under the control of a RNA-IN sense RNA, and
- c. isolating transformed bacterial cells under selection, and
- d. propagating said transformed bacterial cells under conditions that accumulate said DNA replicon,
- whereby said method replaces selection by an antibiotic marker in said DNA replicon, for said DNA replicon isolation or propagation.
A composition of matter for a vector comprising:
- a. an RNA-OUT antisense RNA with at least 90% sequence identity to the sequence set forth as SEQ ID NO:
- 15, operably linked to,
- b. a plasmid, cosmid, or bacterial artificial chromosome DNA replicon, whereby said RNA-out antisense RNA is used to select and propagate said DNA replicon.
A composition of matter for a vector comprising:
- a. a promoter with at least 95% sequence identity to the sequence set forth as SEQ ID NO:
- 6 operable linked to,
- b. a gene of interest,
- whereby said promoter is used to express said gene of interest.
A composition of matter for a vector comprising:
- a. a promoter with at least 95% sequence identity to the sequence set forth as SEQ ID NO:
- 6 operable linked to,
- b. a gene of interest, and
- c. a VARNA
- d. optionally at least one additional immunostimulatory RNA element
- whereby said promoter is used to express said gene of interest and said VARNA is used to increase expression of said gene of interest.
Dependencies are inferred from the claim text.